ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024
ChromaDex Corp. (NASDAQ:CDXC), a leader in NAD+ research and healthy aging, will participate in Renmark's Virtual Non-Deal Roadshow Series on Thursday, August 29, 2024, at 2:00 PM EDT. The event will feature a presentation by key executives, including CEO Rob Fried, Interim CFO James Lee, and VP Finance Wesley Yu.
The live presentation will cover ChromaDex's latest investor information, followed by a Q&A session. While live event registration may be , a replay will be available on the company's investor website. Interested parties can register for the event using the provided link, and are advised to use the latest version of Google Chrome for optimal connectivity.
This virtual roadshow offers an opportunity for stakeholders, investors, and followers to gain insights into ChromaDex's current initiatives and future prospects in the field of healthy aging and NAD+ research.
ChromaDex Corp. (NASDAQ:CDXC), un leader nella ricerca sul NAD+ e nel campo dell'invecchiamento sano, parteciperà alla serie di roadshow virtuali 'Non-Deal' di Renmark il giovedì 29 agosto 2024, alle 14:00 EDT. L'evento includerà una presentazione da parte di dirigenti chiave, tra cui il CEO Rob Fried, il CFO ad interim James Lee e il VP Finance Wesley Yu.
La presentazione dal vivo tratterà le ultime informazioni per gli investitori di ChromaDex, seguita da una sessione di domande e risposte. Sebbene la registrazione per l'evento in diretta possa essere, una replica sarà disponibile sul sito web per investitori dell'azienda. Le parti interessate possono registrarsi per l'evento utilizzando il link fornito e si consiglia di utilizzare l'ultima versione di Google Chrome per una connettività ottimale.
Questo roadshow virtuale offre un'opportunità per azionisti, investitori e seguaci di ottenere approfondimenti sulle attuali iniziative di ChromaDex e sulle prospettive future nel campo dell'invecchiamento sano e della ricerca sul NAD+.
ChromaDex Corp. (NASDAQ:CDXC), un líder en investigación sobre NAD+ y envejecimiento saludable, participará en la serie de roadshows virtuales 'Non-Deal' de Renmark el jueves 29 de agosto de 2024, a las 2:00 PM EDT. El evento contará con una presentación de ejecutivos clave, incluyendo al CEO Rob Fried, al CFO interino James Lee y al VP de Finanzas Wesley Yu.
La presentación en vivo cubrirá la información más reciente para inversores de ChromaDex, seguida de una sesión de preguntas y respuestas. Si bien la inscripción para el evento en vivo puede ser, una repetición estará disponible en el sitio web para inversores de la empresa. Las partes interesadas pueden registrarse para el evento utilizando el enlace proporcionado, y se les aconseja usar la última versión de Google Chrome para una conectividad óptima.
Este roadshow virtual ofrece una oportunidad para que las partes interesadas, inversores y seguidores obtengan información sobre las iniciativas actuales y las perspectivas futuras de ChromaDex en el campo del envejecimiento saludable y la investigación sobre NAD+.
ChromaDex Corp. (NASDAQ:CDXC), NAD+ 연구 및 건강한 노화 분야의 선두주자인 ChromaDex가 2024년 8월 29일 목요일 오후 2시 EDT에 Renmark의 가상 비상장 로드쇼 시리즈에 참여합니다. 이 행사에는 CEO Rob Fried, 임시 CFO James Lee, VP 금융 Wesley Yu를 포함한 주요 경영진의 발표가 포함됩니다.
실시간 발표는 ChromaDex의 최신 투자자 정보를 다룰 것이며, 그 뒤에 Q&A 세션이 이어질 것입니다. 실시간 이벤트 등록이 가능하지만, 회사의 투자자 웹사이트에서 재방송을 볼 수 있습니다. 관심 있는 분들은 제공된 링크를 사용하여 이벤트에 등록할 수 있으며, 최적의 연결을 위해 최신 버전의 Google Chrome을 사용하는 것이 좋습니다.
이 가상 로드쇼는 이해관계자, 투자자 및 팔로워가 ChromaDex의 현재 이니셔티브와 건강한 노화 및 NAD+ 연구 분야의 미래 전망에 대한 통찰력을 얻을 수 있는 기회를 제공합니다.
ChromaDex Corp. (NASDAQ:CDXC), un leader dans la recherche sur le NAD+ et le vieillissement sain, participera à la série de roadshows virtuels 'Non-Deal' de Renmark le jeudi 29 août 2024, à 14h00 EDT. L'événement comprendra une présentation de dirigeants clés, y compris le PDG Rob Fried, le CFO intérimaire James Lee et le VP des finances Wesley Yu.
La présentation en direct couvrira les dernières informations pour les investisseurs de ChromaDex, suivie d'une session de questions-réponses. Bien que l'inscription à l'événement en direct puisse être, un replay sera disponible sur le site Web des investisseurs de l'entreprise. Les parties intéressées peuvent s'inscrire à l'événement en utilisant le lien fourni et sont invitées à utiliser la dernière version de Google Chrome pour une connectivité optimale.
Ce roadshow virtuel offre une occasion aux parties prenantes, investisseurs et abonnés d'obtenir des informations sur les initiatives actuelles de ChromaDex et ses perspectives futures dans le domaine du vieillissement sain et de la recherche sur le NAD+.
ChromaDex Corp. (NASDAQ:CDXC), ein führendes Unternehmen in der NAD+-Forschung und im Bereich gesundes Altern, wird am Donnerstag, den 29. August 2024, um 14:00 Uhr EDT an der virtuellen Non-Deal-Roadshow-Serie von Renmark teilnehmen. Die Veranstaltung wird eine Präsentation von Führungskräften umfassen, darunter CEO Rob Fried, Interim CFO James Lee und VP Finanzen Wesley Yu.
Die Live-Präsentation wird die neuesten Informationen für Investoren von ChromaDex behandeln, gefolgt von einer Frage- und Antwortsitzung. Während die Registrierung für die Live-Veranstaltung möglicherweise möglich ist, wird eine Wiederholung auf der Investorenseite des Unternehmens verfügbar sein. Interessierte Parteien können sich über den bereitgestellten Link für die Veranstaltung registrieren und werden empfohlen, die neueste Version von Google Chrome für eine optimale Konnektivität zu verwenden.
Dieser virtuelle Roadshow bietet Stakeholdern, Investoren und Interessierten die Möglichkeit, Einblicke in die aktuellen Initiativen und zukünftigen Perspektiven von ChromaDex im Bereich gesundes Altern und NAD+-Forschung zu gewinnen.
- None.
- None.
The presentation will feature Rob Fried, Chief Executive Officer; James Lee, Interim Chief Financial Officer; and Wesley Yu, Vice President Finance. Topics to be covered will include the latest investor presentation, followed by a live Q&A. Investors interested in participating in this event will need to register using the link below. As a reminder, registration for the live event may be limited but access to the replay after the event will be on The Company’s Investor website.
REGISTER HERE:
Thursday, August 29, 2024: https://www.renmarkfinancial.com/live-registration/renmark-virtual-non-deal-roadshow-nasdaq-cdxc-g5DKGv-SGk
- To ensure smooth connectivity, please access this link using the latest version of Google Chrome.
For additional information on ChromaDex, visit www.chromadex.com.
About ChromaDex:
ChromaDex Corp. (NASDAQ:CDXC) is the global authority on nicotinamide adenine dinucleotide (NAD+), with a focus on the science of healthy aging. The ChromaDex team, comprised of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to other everyday stressors. NAD+ depletion is a contributor to age-related changes in health and vitality.
Setting the benchmark as the gold standard in scientific rigor, safety, quality, and transparency, ChromaDex is the innovator behind its clinically proven flagship ingredient, Niagen (patented nicotinamide riboside, or NR), the most efficient and superior-quality NAD+ booster available.
Niagen is the active ingredient in ChromaDex’s consumer products, sold as the brand Tru Niagen®, the number one healthy-aging NAD+ supplement in
ChromaDex’s robust patent portfolio protects NR and other NAD+ precursors. ChromaDex maintains a website at www.chromadex.com, to which ChromaDex regularly publishes copies of its press releases, news, and financial information.
†Based on the top-selling dietary supplement brands by revenue per the largest
View source version on businesswire.com: https://www.businesswire.com/news/home/20240823934421/en/
ChromaDex Media Contact:
Kendall Knysch, Senior Director of Media Relations & Partnerships
310-388-6706 ext. 689
kendall.knysch@chromadex.com
ChromaDex Investor Relations Contact:
Ben Shamsian
Lytham Partners
646-829-9701
shamsian@lythampartners.com
Source: ChromaDex Corporation
FAQ
When is ChromaDex (CDXC) participating in Renmark's Virtual Non-Deal Roadshow?
Who will be presenting at ChromaDex's (CDXC) virtual roadshow event?
What topics will be covered in ChromaDex's (CDXC) virtual roadshow presentation?
How can investors register for ChromaDex's (CDXC) virtual roadshow event?
Will there be a replay available for ChromaDex's (CDXC) virtual roadshow presentation?
